Primary membranous glomerulonephritis Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

22Recruiting trials

🩺

45Specialists

Regulatory Watchboard

10 events

Oct 2026A Phase I Study of YK012 in Primary Membranous Nephropathy

Excyte Biopharma Ltd — PHASE1

TrialNOT YET RECRUITING

Feb 2026Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

The First Affiliated Hospital of Zhejiang Chinese Medical University — EARLY_PHASE1

TrialNOT YET RECRUITING

Dec 2025Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

Guangdong Hengrui Pharmaceutical Co., Ltd — PHASE2

TrialRECRUITING

Sep 2025A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

Vertex Pharmaceuticals Incorporated — PHASE2, PHASE3

TrialRECRUITING

Sep 2025Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

Alexion Pharmaceuticals, Inc. — PHASE2

TrialRECRUITING

Aug 2025A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

Climb Bio, Inc. — PHASE2

TrialRECRUITING

Jun 2025A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

Shanghai JMT-Bio Inc. — PHASE2

TrialNOT YET RECRUITING

May 2025A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Biogen — PHASE3

TrialRECRUITING

Mar 2025Study of YK012 in Primary Membranous Nephropathy

Excyte Biopharma Ltd — PHASE1

TrialRECRUITING

Nov 2024An Outcome Analysis of Primary Membranous Nephropathy

Mario Negri Institute for Pharmacological Research

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Primary membranous glomerulonephritis.
Check the disease page for updates →

Clinical Trial Landscape

22 active trials

5Phase 3

1Phase 4

6Phase 2

3Phase 1

1N/A

3Unknown

3PHASE2, PHASE3

22Total recruiting

Search clinical trials for Primary membranous glomerulonephritis →

Recent News & Research

No recent news articles indexed yet for Primary membranous glomerulonephritis.
Search PubMed for Primary membranous glomerulonephritis →

Browse all Primary membranous glomerulonephritis news →

Specialist Network

Top 6 by expertise

Pam Winterberg, MD

Vera Therapeutics

📍 ATLANTA, GA

Score 81 trial

Andrew Blair, MD

Walden Biosciences

Score 81 trial

Giuseppe Remuzzi, M.D.

Istituto Di Ricerche Farmacologiche Mario Negri

Score 73 trials

Giuseppe Remuzzi, MD

Istituto Di Ricerche Farmacologiche Mario Negri

Score 77 trials

Fernando Fervenza, MD, PhD, M.D

Mayo Clinic

📍 ROCHESTER, MN

Score 62 trials

JESUS EGIDO, MD, PhD

IIS Fundación Jiménez Díaz, Madrid. Spain

Score 61 trial

View all Primary membranous glomerulonephritis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰